A Chinese hospital specializing in cardiovascular care, Fuwai Hospital under the Chinese Academy of Medical Sciences (CAMS), has adopted a new radiation-free percutaneous intervention for the treatment of heart diseases.

The treatment uses ultrasound imaging to guide the minimally invasive insertion of instruments through the peripheral blood vessels into the heart.

Unlike traditional methods, this approach eliminates the need for surgery and radiation, allowing patients to stay awake throughout the procedure. It is also suitable for pregnant women, those with allergies and cancer patients, as it avoids the risks associated with radiation exposure. The process does not require costly imported equipment, making it more accessible and technically feasible.

Fuwai Hospital has so far developed over 17 new treatments for cardiovascular diseases, such as congenital heart disease, valvular disease and arrhythmia, securing 65 patents in the process. Furthermore, the hospital has developed various therapeutic instruments, including an ultrasonic catheter and a surgical robot, with 23 of these devices available both in China and internationally.

The procedure is expected to enhance the capacity of primary medical services, providing effective heart disease treatments to outpatients. This improvement will extend access to heart care in countries and regions with limited medical resources. This form of heart treatment has received funding from the United Nations.

Medical teams from Fuwai Hospital have also been active internationally, bringing Chinese cardiovascular treatment solutions to over 30 countries, including France, Germany, Canada, Russia and Kenya.

(With input from Xinhua)